GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Marksans Pharma MARKSANS.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

308.75

+1.66%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2025

Revenue

₹26.23bn

FY2016FY2025

Net income

₹3.81bn

FY2016FY2025

Free cash flow

₹337.4m

FY2016FY2025

Shareholders' equity

₹24.67bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₹26.23bn₹21.77bn₹18.52bn₹14.91bn₹13.76bn₹11.34bn₹10.00bn₹9.13bn₹7.67bn₹8.93bn
Gross profit₹13.93bn₹10.83bn₹9.31bn₹7.43bn₹7.58bn₹5.89bn₹4.63bn₹3.57bn₹2.85bn₹3.56bn
Operating income₹4.66bn₹3.88bn₹2.99bn₹2.14bn₹3.03bn₹1.66bn₹1.09bn₹516.0m₹28.3m₹1.04bn
Net income₹3.81bn₹3.14bn₹2.66bn₹1.85bn₹2.36bn₹1.17bn₹764.6m₹329.4m₹88.4m₹785.1m
Diluted earnings per share8.406.935.884.585.762.821.840.790.211.89

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₹32.40bn—₹21.90bn₹16.40bn₹12.28bn₹8.97bn₹8.04bn₹7.32bn₹7.52bn₹7.20bn
Cash and short-term investments₹7.05bn—₹7.15bn₹3.47bn₹2.09bn₹939.3m₹328.5m₹397.2m₹250.5m₹350.2m
Total liabilities₹7.73bn—₹4.45bn₹4.38bn₹3.42bn₹2.61bn₹2.61bn₹2.61bn₹3.18bn₹2.75bn
Debt₹2.86bn—₹1.07bn₹827.3m₹330.7m₹238.4m₹1.10bn₹1.27bn₹1.21bn₹1.00bn
Shareholders' equity₹24.67bn—₹17.45bn₹12.02bn₹8.86bn₹6.36bn₹5.42bn₹4.71bn₹4.33bn₹4.45bn
Shares outstanding453m453m453m403m409m415m416m419m426m415m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₹2.07bn₹2.30bn₹2.37bn₹992.6m₹1.79bn₹2.10bn₹274.0m₹500.9m₹88.4m₹308.0m
Capital spending−₹1.73bn−₹2.09bn−₹536.3m−₹463.3m−₹464.2m−₹596.3m−₹131.5m−₹389.4m−₹277.5m−₹1.32bn
Free cash flow₹337.4m₹215.7m₹1.84bn₹529.3m₹1.32bn₹1.50bn₹142.5m₹111.6m−₹189.1m−₹1.01bn
Dividends paid−₹271.9m−₹226.6m−₹101.7m−₹105.8m−₹40.9m−₹295.0m−₹44.4m−₹24.6m−₹145.3m−₹179.6m

Latest quarters

By quarter end

Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024
Revenue₹7.54bn₹7.20bn₹6.20bn₹7.08bn₹6.82bn₹6.42bn₹5.91bn₹5.60bn
Gross profit₹4.38bn₹4.12bn₹3.58bn₹3.83bn₹3.83bn₹3.84bn₹3.29bn₹2.90bn
Operating income₹1.36bn₹1.18bn₹770.2m₹1.03bn₹1.18bn₹1.16bn₹1.08bn₹885.8m
Net income₹1.13bn₹982.5m₹583.2m₹905.4m₹1.05bn₹967.2m₹887.5m₹782.9m
Diluted earnings per share2.502.171.292.002.312.141.961.73
Cash from operations—₹751.0m—₹2.07bn—₹771.0m—₹2.30bn
Capital spending—−₹731.0m—−₹1.73bn—−₹759.0m—−₹2.09bn
Free cash flow—₹20.0m—₹337.0m—₹12.0m—₹216.0m
Total assets—₹34.42bn—₹32.40bn—₹29.11bn—₹26.81bn
Cash and short-term investments—₹6.71bn—₹7.09bn—₹6.82bn—₹7.07bn
Debt—₹2.90bn—₹2.86bn—₹1.79bn—₹2.19bn
Shareholders' equity—₹26.88bn—₹24.67bn—₹22.81bn—₹20.65bn

Financial ratios

Data as of 12 Sept 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin39.2%56.4%50.7%50.3%49.5%54.8%——
Operating margin17.9%19.7%20.0%18.7%34.9%40.1%——
Net margin14.2%14.5%14.4%14.4%12.5%17.4%——
Return on equity13.8%15.4%15.2%15.3%15.4%26.9%——
Return on assets10.8%11.7%11.7%12.2%11.3%19.4%——
Free cash flow yield4.1%2.5%2.9%1.9%1.1%1.7%——
Revenue growth12.5%20.5%17.6%25.1%8.2%21.2%——
Earnings growth9.8%21.3%17.8%44.3%-22.6%97.5%——
Current ratio5.17x4.62x4.78x4.91x3.37x3.02x——
Debt to equity0.02x0.02x0.03x0.03x0.06x0.03x——
Equity ratio78.3%76.1%77.0%79.7%73.3%72.2%——
Interest coverage21.92x44.22x38.80x37.99x61.21x68.64x——
R&D as a share of sales——1.1%0.9%1.3%0.9%0.7%0.6%
Buybacks as a share of market value-0.1%-0.0%0.1%-12.5%1.6%1.4%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue20.7%18.3%12.7%
Operating income29.6%23.0%11.3%
Net income27.3%26.6%13.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin51.6%51.0%51.6%48.6%
Operating margin17.8%16.8%17.2%15.1%
Net margin14.5%14.1%14.1%12.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings21.442.827.412.710.421.59.135.4192.421.1
Price to sales3.16.23.91.61.82.20.71.32.21.9

Dividends and splits

Per share, in the currency the company pays

Paid for 12 years. Last went ex-dividend on 20 Aug 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.800.600.500.250.250.100.050.05
  • 10-for-1 split · 11 Mar 2008

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.